Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jul 23;93(15):8078-82.
doi: 10.1073/pnas.93.15.8078.

Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors

Affiliations

Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors

J P Huidobro-Toro et al. Proc Natl Acad Sci U S A. .

Abstract

Amide derivatives of fatty acids were recently isolated from cerebrospinal fluid of sleep-deprived animals and found to induce sleep in rats. To determine which brain receptors might be sensitive to these novel neuromodulators, we tested them on a range of receptors expressed in Xenopus oocytes. cis-9,10-Octadecenamide (ODA) markedly potentiated the action of 5-hydroxytryptamine (5-HT) on 5-HT2A and 5-HT2C receptors, but this action was not shared by related compounds such as oleic acid and trans-9,10-octacenamide. ODA was active at concentrations as low as 1 nM. The saturated analog, octadecanamide, inhibited rather than potentiated 5-HT2C responses. ODA had either no effect or only weak effects on other receptors, including muscarinic cholinergic, metabotropic glutamate, GABA(A), N-methyl-D-asparate, or alpha-amino-3-hydroxy-5-methyl-4-isoxozolepropionic acid receptors. Modulation of 5-HT2 receptors by ODA and related lipids may represent a novel mechanism for regulation of receptors that activate G proteins and thereby play a role in alertness, sleep, and mood as well as disturbances of these states.

PubMed Disclaimer

References

    1. Pharmacol Ther. 1995 May;66(2):339-68 - PubMed
    1. J Psychiatry Neurosci. 1995 May;20(3):215-25 - PubMed
    1. Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11000-4 - PubMed
    1. FASEB J. 1995 Nov;9(14):1454-62 - PubMed
    1. Mol Pharmacol. 1995 Dec;48(6):1099-107 - PubMed

Publication types

MeSH terms

LinkOut - more resources